Market research
IV8.F Invitae Corporation
F EUR Not available
Latest close
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 32M
- P/E ratio
- Not available
- Analyst target
- 40.44
- Dividend yield
- Not available
- Beta
- 1.59
Profile
Company facts
- Exchange
- F
- Currency
- EUR
- Sector
- Not available
- Industry
- Not available
- ISIN
- US46185L1035
- Market cap
- 32M
- P/E ratio
- Not available
- Analyst target
- 40.44
- Dividend yield
- Not available
- Beta
- 1.59
About
About Invitae Corporation
Invitae Corporation, a medical genetics company, that provides genetic information to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, precision oncology, women's health, rare diseases, and pharmacogenomics; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California. On February 13, 2024, Invitae Corporation, along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of New Jersey.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the IV8.F discussion.
5 years, 5 months ago
Invitae Corporation is currently in a long term downtrend where the price is trading 26.9% below its 200 day moving average.
From a valuation standpoint, the stock is 98.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 19.0.
Invitae Corporation's total revenue rose by 51.5% to $100M since the same quarter in the previous year.
Its net income has dropped by 213.4% to $-241M since the same quarter in the previous year.
Finally, its free cash flow fell by 127.7% to $-122M since the same quarter in the previous year.
Based on the above factors, Invitae Corporation gets an overall score of 2/5.